`
`
`Filed: December 29, 2020
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`___________________
`
`EDWARDS LIFESCIENCES CORPORATION AND
`EDWARDS LIFESCIENCES LLC,
`
`PETITIONERS,
`
`V.
`
`COLIBRI HEART VALVE LLC,
`
`PATENT OWNER.
`___________________
`
`Case No. IPR2020-01649
`U.S. Patent No. 9,125,739
`___________________
`
`
`DECLARATION OF MIEKE K. MALMBERG IN SUPPORT OF PATENT
`OWNER’S PRELIMINARY RESPONSE
`UNDER 35 U.S.C. § 313 AND 37 C.F.R. § 42.107
`
`Colibri Heart Valve LLC, Exhibit 2009, Page 1 of 4
`
`
`
`Pursuant to 28 U.S.C. § 1746, I, Mieke K. Malmberg, hereby declare as
`
`follows:
`
`1.
`
`I am over the age of eighteen and otherwise competent to make this
`
`declaration. I have personal knowledge of the facts contained in this declaration,
`
`and they are true and correct.
`
`2.
`
`I am a Partner with the law firm of Skiermont Derby LLP, which
`
`represents the Patent Owner, Colibri Heart Valve, LLC (“Colibri”) in this
`
`proceeding. I am local counsel for Colibri in the related district court litigation,
`
`Case No. 8:20-cv-00847-DOC-JDE, which was filed on May 4, 2020, in the
`
`Central District of California Southern Division (“CDCA Litigation”). (Ex. 2001,
`
`1.)
`
`3. Medtronic CoreValve LLC (“Medtronic”) is the Defendant in the
`
`CDCA Litigation.
`
`4.
`
`On September 4, 2020, Medtronic moved for a stay of the CDCA
`
`Litigation pending inter partes review. (Ex. 2008.)
`
`5.
`
`Also on September 4, 2020, the court entered a scheduling order
`
`setting a jury trial for September 14, 2021. (Exs. 2003, 2010.)
`
`6.
`
`During an in-person status conference conducted with the District
`
`Court on November 17, 2020, Judge Carter denied Medtronic’s request for a stay
`
`and indicated that the September 14, 2021 jury trial “would not move under any
`
`
`
`
`
`Colibri Heart Valve LLC, Exhibit 2009, Page 2 of 4
`
`
`
`circumstances.” (Ex. 2004, 2.) Judge Carter also requested the parties submit
`
`additional dates for the schedule, including Markman briefing. (Id.)
`
`7.
`
`On November 24, 2020, Judge Carter entered additional dates into the
`
`case schedule, preserving the September 14, 2020 trial date. (Ex. 2005.)
`
`8.
`
`On November 6, 2020, Medtronic served invalidity contentions on
`
`Colibri in the CDCA Litigation.
`
`9.
`
`In those invalidity contentions, Medtronic argues that the ’739 patent
`
`is invalid based on the following references/combinations:
`
` Patent No. 5,840,081 (“Andersen”), in view of United States Patent
`
`No. 6,077,295 (“Limon”), U.S. Patent No. 7,025,780 (“Gabbay”),
`
`WO/0015147 (“Phelps”) and/or U.S. Patent No. 5,961,549
`
`(“Nguyen”);
`
` United States Patent No. 5,855,601 (“Bessler”) in view of U.S. Patent
`
`Publication No. 2001/0044633 (“Klint”) and U.S. Patent No.
`
`5,332,402 (“Teitelbaum”);
`
` Bessler and Teitelbaum;
`
` Bessler in view of U.S. Patent No. 5,957,949 (“Leonhardt”), Klint,
`
`U.S. Patent No. 4,218,782 (“Rygg”) and/or U.S. Pat. No. 5,713,950
`
`(“Cox”);
`
` Bessler in view of Leonhardt, Rygg and/or Cox;
`
`
`
`
`
`Colibri Heart Valve LLC, Exhibit 2009, Page 3 of 4
`
`
`
` United States Patent No. 6,425,916 (“Garrison”) in view of
`
`Leonhardt, Rygg, Cox and/or Nguyen;
`
` Garrison and Nguyen;
`
` Leonhardt, Rygg and/or Cox;
`
` Limon, in view of Leonhardt, Rygg and/or Cox; and
`
` United States Patent Publication No. 2005/0113910 (“Paniagua”).
`
`Under penalty of perjury, I declare the above statements as true and accurate
`
`to the best of my recollection. I further state that these statements are made with
`
`the knowledge that willful false statements and the like are punishable by fine or
`
`imprisonment, or both under Section 1001 of Title 18 of the U.S. Code.
`
`
`
`Executed on this 29th day of December, 2020.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /s/Mieke K. Malmberg
`
`
`
`Mieke K. Malmberg
`
`
`
`
`
`Colibri Heart Valve LLC, Exhibit 2009, Page 4 of 4
`
`